News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
The IARC is now an associate partner of the 2022-2027 Local Health Contract
IARC/LinkedIn
Mar 18, 2025, 07:44

The IARC is now an associate partner of the 2022-2027 Local Health Contract

IARC shared a post on LinkedIn:

“The IARC is now an associate partner of the 2022-2027 Local Health Contract, signed by Dr Elisabete Weiderpass during a ceremony at the City Hall of Lyon on 10 March.

This contract aims to improve the health of Lyonnais and reduce inequalities by mobilizing local actors.”

Local Health Contract

cancer Elisabete Weiderpass IARC Local Health Contract OncoDaily Oncology
Special Coverage
Stories
Jun 1, 2025, 17:19
Shrenik Shah’s Story from Cancer Survivor to Global Advocate: From Silence to Stages
Insight
Jun 1, 2025, 17:02
Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney
Blog
Jun 1, 2025, 16:55
Oriol Mirallas: Early Data on SYNC-T Therapy for mCRPC Presented at ASCO 2025
Blog
Jun 1, 2025, 16:52
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Insight
Jun 1, 2025, 16:46
Shanda Blackmon: First trial of CAR-T cell cancer treatment for solid tumor response
Oncolibrary
Jun 1, 2025, 16:39
MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment
Opinion
Jun 1, 2025, 16:37
Massimo Di Maio: Overall Survival Analysis Should NOT be Adjusted for Subsequent Treatments
Blog
Jun 1, 2025, 16:37
Paolo Tarantino Shares DB06 Biomarker Analysis Insights from ASCO 2025
Insight
Jun 1, 2025, 16:36
Rebecca Shatsky: It’s high time for an oral taxane in breast cancer
Blog
Jun 1, 2025, 16:26
Runcie C.W. Chidebe: Project PINK BLUE is Exhibiting at the ASCO25 Annual Meeting
Blog
Jun 1, 2025, 16:26
Oyepeju Abioye-Akintola: Thank you to the ecancer team for the wonderful interview at ASCO 2025
Blog
Jun 1, 2025, 16:25
Sarah Sammons: 50% of patients do not make it to second line therapy in mTNBC